High purity lipopeptides

CAFC
  • US 8,129,342 B2
  • Filed: 09/22/2010
  • Issued: 03/06/2012
  • Est. Priority Date: 01/20/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition obtained by a process comprising the step of forming a daptomycin aggregate, the composition comprising daptomycin of greater than or about 93% purity relative to impurities 1-14 defined by peaks 1-14 shown in FIG. 12 and having less than 4% of anhydro-daptomycin and having less than 4% of β

  • -isomer of daptomycin.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×